This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lorus Therapeutics Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Paul B Percheson: Innovator in Immunomodulating Compositions
Introduction
Paul B Percheson is a notable inventor based in Uxbridge, CA. He has made significant contributions to the field of immunology through his innovative research and development of immunomodulating compositions. His work focuses on addressing immune system disorders, showcasing his commitment to advancing medical science.
Latest Patents
Paul B Percheson holds a patent for "Immunomodulating compositions for treatment of immune system disorders." This invention relates to a composition that serves as an immunomodulator, comprising small molecular weight components of less than 3000 daltons. The composition has several key properties, including the ability to stimulate monocytes and macrophages both in vitro and in vivo. It modulates tumor necrosis factor production and contains no measurable levels of various interleukins and cytokines. Additionally, it exhibits an anti-proliferative effect on malignant mouse hybridoma cell lines while showing no cytotoxicity to human peripheral blood mononuclear cells or lymphocytes. The invention also outlines a method for preparing the composition and its applications in treating diseases with an immunological component.
Career Highlights
Paul B Percheson is associated with Lorus Therapeutics Inc., where he continues to contribute to the development of innovative therapeutic solutions. His work has been instrumental in advancing the understanding of immunomodulation and its potential applications in medicine.
Collaborations
Paul collaborates with esteemed colleagues, including Romeo G Rang, to further enhance the impact of their research and innovations in the field of immunology.
Conclusion
Paul B Percheson exemplifies the spirit of innovation in the medical field through his groundbreaking work on immunomodulating compositions. His contributions are paving the way for new treatments for immune system disorders, highlighting the importance of research and collaboration in advancing healthcare solutions.